Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes

Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes

B Heinrich,1 J Klein,1 M Delic,1 K Goepfert,1 V Engel,1 L Geberzahn,1 M Lusky,2 P Erbs,2 X Preville,3 M Moehler1 1First Department of Internal Medicine, University Medical Center Mainz, Mainz, Germany; 2Transgene SA, Illkirch-Graffenstaden, 3Amoneta Diagnostics, Huningue, France Abstract: Oncolyti...

Full description

Bibliographic Details
Main Authors: Heinrich B, Klein J, Delic M, Goepfert K, Engel V, Geberzahn L, Lusky M, Erbs P, Preville X, Moehler M
Format: Article
Language:English
Published: Dove Medical Press 2017-05-01
Series:OncoTargets and Therapy
Subjects:
Oncolytic virus
vaccinia virus
immunogenic cell death
dendritic cells
cytotoxic T lymphocytes
immunotherapy
Online Access:https://www.dovepress.com/immunogenicity--of-oncolytic-vaccinia-viruses-jx-gfp-and-tg6002-in-a-h-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/immunogenicity--of-oncolytic-vaccinia-viruses-jx-gfp-and-tg6002-in-a-h-peer-reviewed-article-OTT

Similar Items